| Jun 24 |
How Lilly is joining Novo in the crusade to circumvent Medicare's block on weight loss drugs
|
| Jun 24 |
ResMed Stock Dives. Blame Eli Lilly’s Zepbound Trials for Sleep Apnea.
|
| Jun 24 |
Top Stock Movers Now: Affirm, Nvidia, ResMed, and More
|
| Jun 24 |
Abbott's (ABT) EPD Expansion Continues Despite FX Headwind
|
| Jun 24 |
Valneva's (VALN) CHIKV Vaccine Gets Health Canada's Approval
|
| Jun 24 |
Why a Pair of Eli Lilly Clinical Trials Sent ResMed Stock Tumbling
|
| Jun 24 |
Eli Lilly seeks to expand Zepbound use to treat sleep apnea
|
| Jun 24 |
Best Momentum Stock to Buy for June 24th
|
| Jun 24 |
Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes
|
| Jun 24 |
ResMed Inc. (NYSE:RMD) Shares Could Be 24% Below Their Intrinsic Value Estimate
|
